Lucid Diagnostics (LUCD) Net Income (QoQ) (2020 - 2026)
Lucid Diagnostics (LUCD) Net Income (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Lucid Diagnostics | 129.44 Mn | 101.56 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.49% |
| Dec 31, 2025 | -56.45% |
| Sep 30, 2025 | -134.22% |
| Jun 30, 2025 | 83.50% |
| Mar 31, 2025 | -133.15% |
| Dec 31, 2024 | 6.71% |
| Sep 30, 2024 | -12.41% |
| Jun 30, 2024 | -3.70% |
| Mar 31, 2024 | 2.01% |
| Dec 31, 2023 | 23.78% |
| Sep 30, 2023 | -24.84% |
| Jun 30, 2023 | 29.95% |
| Mar 31, 2023 | -8.84% |
| Dec 31, 2022 | -4.04% |
| Sep 30, 2022 | 1.88% |
| Jun 30, 2022 | -19.19% |
| Mar 31, 2022 | -8.53% |
| Dec 31, 2021 | -62.51% |
| Sep 30, 2021 | -12.88% |
| Jun 30, 2021 | -68.71% |